KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Short-term Investments (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Short-term Investments for 17 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 14.07% to $1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Dec 2025, down 14.07% year-over-year, with the annual reading at $1.0 billion for FY2025, 14.07% down from the prior year.
  • Short-term Investments for Q4 2025 was $1.0 billion at Bio-Rad Laboratories, down from $1.0 billion in the prior quarter.
  • The five-year high for Short-term Investments was $1.4 billion in Q1 2023, with the low at $5.6 million in Q1 2021.
  • Average Short-term Investments over 5 years is $554.5 million, with a median of $241.4 million recorded in 2021.
  • The sharpest move saw Short-term Investments skyrocketed 22762.64% in 2022, then plummeted 99.6% in 2024.
  • Over 5 years, Short-term Investments stood at $5.6 million in 2021, then changed by 0.0% to $5.6 million in 2022, then changed by 0.0% to $5.6 million in 2023, then soared by 20907.14% to $1.2 billion in 2024, then fell by 14.07% to $1.0 billion in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $1.0 billion, $1.0 billion, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.